People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Comet Therapeutics, Inc. | — | Pharma | Series A | $14.1M | $435.3M | 2019 |
ART TAVERAS, PH.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ART TAVERAS, PH.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bernardus Machielse | 1 | 2 |
| DAVID DE GRAAF, PH.D. | 1 | 2 |
| ENEJ KUSCER, PH.D. | 1 | 1 |
| PETER VAN VLASSELAER, PH.D. | 1 | 1 |
| HENRIJETTE RICHTER, PH.D. | 1 | 1 |
| LUCAS DE BREED | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.